Corvidia Therapeutics Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.1B
- Investors
-
1
Corvidia Therapeutics General Information
Description
Developer of next-generation precision cardiovascular therapies designed to harness the power of intersections. The company's cardiovascular therapies aid to identify patients with a unique sensitivity to specific biologic pathways that focuses on the research, development and commercialization of transformative therapies for cardio-renal diseases, enabling medical providers to offer rapid development of therapies targeting those pathways.
Contact Information
Website
www.corvidiatx.comCorporate Office
- 35 Gatehouse Drive
- Waltham, MA 02451
- United States
Corporate Office
- 35 Gatehouse Drive
- Waltham, MA 02451
- United States
Corvidia Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 11-Jun-2020 | $2.1B | Completed | Generating Revenue | ||
| 4. Early Stage VC | 24-Mar-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 25-Apr-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 17-Feb-2016 | $31.8M | $31.8M | Completed | Startup | |
| 1. Seed Round | 01-Jan-2015 | Completed | Startup |
Corvidia Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Corvidia Therapeutics Comparisons
Industry
Financing
Details
Corvidia Therapeutics Competitors (59)
One of Corvidia Therapeutics’s 59 competitors is Attune Pharmaceuticals, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Attune Pharmaceuticals | Venture Capital-Backed | New York, NY | ||||
| Cellaion | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Kriya Therapeutics | Venture Capital-Backed | Morrisville, NC |
Corvidia Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Corvidia Therapeutics Patents
Corvidia Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020223565-A1 | Anti-il-6 antibody formulation | Inactive | 01-May-2019 | ||
| WO-2019136312-A1 | Methods for treating il-6 mediated inflammation without immunosuppression | Inactive | 05-Jan-2018 | ||
| WO-2018144773-A1 | Treatment of diuretic resistance | Inactive | 01-Feb-2017 | ||
| WO-2018136803-A1 | Apoc-ii mimetic peptides | Inactive | 19-Jan-2017 | ||
| WO-2018136803-A8 | Apoc-ii mimetic peptides | Inactive | 19-Jan-2017 | C07K14/775 |
Corvidia Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Corvidia Therapeutics Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Andera Partners | PE/Buyout | Minority | ||
| Apple Tree Partners (ATP) | Venture Capital | Minority | ||
| AstraZeneca | Corporation | Minority | ||
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Fresenius Medical Care Ventures | Corporate Venture Capital | Minority |
Corvidia Therapeutics FAQs
-
When was Corvidia Therapeutics founded?
Corvidia Therapeutics was founded in 2015.
-
Where is Corvidia Therapeutics headquartered?
Corvidia Therapeutics is headquartered in Waltham, MA.
-
What is the size of Corvidia Therapeutics?
Corvidia Therapeutics has 4 total employees.
-
What industry is Corvidia Therapeutics in?
Corvidia Therapeutics’s primary industry is Biotechnology.
-
Is Corvidia Therapeutics a private or public company?
Corvidia Therapeutics is a Private company.
-
What is the current valuation of Corvidia Therapeutics?
The current valuation of Corvidia Therapeutics is .
-
What is Corvidia Therapeutics’s current revenue?
The current revenue for Corvidia Therapeutics is .
-
How much funding has Corvidia Therapeutics raised over time?
Corvidia Therapeutics has raised $91.8M.
-
Who are Corvidia Therapeutics’s investors?
Andera Partners, Apple Tree Partners (ATP), AstraZeneca, Cormorant Asset Management, and Fresenius Medical Care Ventures are 5 of 10 investors who have invested in Corvidia Therapeutics.
-
Who are Corvidia Therapeutics’s competitors?
Attune Pharmaceuticals, Cellaion, Sorrento Therapeutics, Sangamo Therapeutics, and Kriya Therapeutics are some of the 59 competitors of Corvidia Therapeutics.
-
When was Corvidia Therapeutics acquired?
Corvidia Therapeutics was acquired on 11-Jun-2020.
-
Who acquired Corvidia Therapeutics?
Corvidia Therapeutics was acquired by Novo Nordisk.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
